Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dale

Showing results (291-300 of 320) with videos related to

Pageof 32
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
3-amino-4-sulfonylpyridinone acetamide and related pyridothiadiazine thrombin inhibitorsPhilip E J Sanderson, Kellie J Cutrona, Kelly L Savage, et al.
Nature Communications|July 17, 2025
Synchronized seasonal excretion of multiple coronaviruses coincides with high rates of coinfection in immature batsAlison J Peel, Manuel Ruiz-Aravena, Karan Kim, et al.
Trials|January 3, 2025
Benzodiazepine agonist treatment for patients with benzodiazepine dependence undergoing opioid agonist treatment: a study protocol for the randomized controlled trial BMX-BARFatemeh Chalabianloo, Lars Thore Fadnes, Jörg Assmus, et al.
Emerging Infectious Diseases|June 25, 2025
Borrelia Lineages Adjacent to Zoonotic Clades in Black Flying Foxes (Pteropus alecto), Australia, 2018-2020Taylor B Verrett, Caylee A Falvo, Evelyn Benson, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Unexpected enhancement of thrombin inhibitor potency with o-aminoalkylbenzylamides in the P1 positionKenneth E Rittle, James C Barrow, Kellie J Cutrona, et al.
Implementation Science : IS|January 26, 2023
Evaluating remote facilitation intensity for multi-national translation of nurse-initiated stroke protocols (QASC Australasia): a protocol for a cluster randomised controlled trialO Fasugba, S Dale, E McInnes, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Low molecular weight thrombin inhibitors with excellent potency, metabolic stability, and oral bioavailabilityMatthew M Morrissette, Kenneth J Stauffer, Peter D Williams, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
P3 optimization of functional potency, in vivo efficacy and oral bioavailability in 3-aminopyrazinone thrombin inhibitors bearing non-charged groups at the P1 positionRichard C A Isaacs, Christina L Newton, Kellie J Cutrona, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitorsRichard C A Isaacs, Christina L Newton, Kellie J Cutrona, et al.
Advances in Radiation Oncology|December 22, 2021
Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective StudyGrace J Kim, Evan D Buckley, James E Herndon, et al.
Pageof 32

Showing results (291-300 of 320) with videos related to

Sort By:
Pageof 32
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
3-amino-4-sulfonylpyridinone acetamide and related pyridothiadiazine thrombin inhibitorsPhilip E J Sanderson, Kellie J Cutrona, Kelly L Savage, et al.
Nature Communications|July 17, 2025
Synchronized seasonal excretion of multiple coronaviruses coincides with high rates of coinfection in immature batsAlison J Peel, Manuel Ruiz-Aravena, Karan Kim, et al.
Trials|January 3, 2025
Benzodiazepine agonist treatment for patients with benzodiazepine dependence undergoing opioid agonist treatment: a study protocol for the randomized controlled trial BMX-BARFatemeh Chalabianloo, Lars Thore Fadnes, Jörg Assmus, et al.
Emerging Infectious Diseases|June 25, 2025
Borrelia Lineages Adjacent to Zoonotic Clades in Black Flying Foxes (Pteropus alecto), Australia, 2018-2020Taylor B Verrett, Caylee A Falvo, Evelyn Benson, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Unexpected enhancement of thrombin inhibitor potency with o-aminoalkylbenzylamides in the P1 positionKenneth E Rittle, James C Barrow, Kellie J Cutrona, et al.
Implementation Science : IS|January 26, 2023
Evaluating remote facilitation intensity for multi-national translation of nurse-initiated stroke protocols (QASC Australasia): a protocol for a cluster randomised controlled trialO Fasugba, S Dale, E McInnes, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Low molecular weight thrombin inhibitors with excellent potency, metabolic stability, and oral bioavailabilityMatthew M Morrissette, Kenneth J Stauffer, Peter D Williams, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
P3 optimization of functional potency, in vivo efficacy and oral bioavailability in 3-aminopyrazinone thrombin inhibitors bearing non-charged groups at the P1 positionRichard C A Isaacs, Christina L Newton, Kellie J Cutrona, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitorsRichard C A Isaacs, Christina L Newton, Kellie J Cutrona, et al.
Advances in Radiation Oncology|December 22, 2021
Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective StudyGrace J Kim, Evan D Buckley, James E Herndon, et al.
Pageof 32